郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis.

期刊：Journal of medicinal chemistry发表年份：2017作者：Malliga R Iyer; Resat Cinar; Alexis Katz; Michael Gao; Katalin Erdelyi; Tony Jourdan; Nathan J Coffey; Pal Pacher; George Kunos
阅读更多 →

药效评价Discovery of new muscarinic acetylcholine receptor antagonists from Scopolia tangutica.

期刊：Scientific reports发表年份：2017作者：Nana Du; Yanfang Liu; Xiuli Zhang; Jixia Wang; Jianqiang Zhao; Jian He; Han Zhou; Lijuan Mei; Xinmiao Liang
阅读更多 →

药效评价Phosphorylation regulates activity of 7-dehydrocholesterol reductase (DHCR7), a terminal enzyme of cholesterol synthesis.

期刊：The Journal of steroid biochemistry and molecular biology发表年份：2017作者：Anika V Prabhu; Winnie Luu; Laura J Sharpe; Andrew J Brown
阅读更多 →

药效评价ALD1613, a Novel Long-Acting Monoclonal Antibody to Control ACTH-Driven Pharmacology.

期刊：Endocrinology发表年份：2017作者：Andrew L Feldhaus; Katie Anderson; Benjamin Dutzar; Ethan Ojala; Patricia Dianne McNeill; Pei Fan; Jenny Mulligan; Sam Marzolf; Charlie Karasek; Michelle Scalley-Kim; Erica Stewart; Jens Billgren; Vanessa Rubin; Kathleen Schneider; David Jurchen; Kat
阅读更多 →